Log In
Print this Print this

fedovapagon (formerly VA106483, VT483)

  Manage Alerts
Collapse Summary General Information
Company Vantia Therapeutics Ltd.
DescriptionOral vasopressin 2 (V2) receptor agonist
Molecular Target Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 2 (V2) receptor agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today